Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects

Patients with hematological disorders and severe thrombocytopenia require extensive and iterative platelet transfusion support. In these patients, platelet transfusion refractoriness represents a serious adverse transfusion event with major outcomes for patient care. Recipient alloantibodies against...

Descripción completa

Detalles Bibliográficos
Autores principales: Couvidou, Adèle, Rojas-Jiménez, Gabriel, Dupuis, Arnaud, Maître, Blandine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947338/
https://www.ncbi.nlm.nih.gov/pubmed/36845153
http://dx.doi.org/10.3389/fimmu.2023.1125367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947338/
https://www.ncbi.nlm.nih.gov/pubmed/36845153
http://dx.doi.org/10.3389/fimmu.2023.1125367

Ejemplares similares